Search

Displaying results 1941 - 1950 of 10000 in total
  1. Drug

    P-BCMA-101

    go.drugbank.com/drugs/DB17371
    Investigational

    P-BCMA-101 is an autologous CAR-T therapy developed using Poseida’s piggyBac platform technology.

  2. Drug

    WU-NK-101

    go.drugbank.com/drugs/DB18350
    Investigational

    WU-NK-101 is an allogeneic CD3-depleted, CD56-enriched activated natural killer-cell product

  3. Drug

    TAK-075 Free base

    go.drugbank.com/drugs/DB18268
    Experimental

    Synonyms: TAK-075 Free base, Pyrazolo(1,5-a)pyrimidine-3-carboxamide, n-(1-ethyl-1-(4-ethylphenyl)propyl)-4,5,6,7-tetrahydro-2,7,7-trimethyl-5-phenyl-, (5r)-
  4. Drug

    Rhodamine 123 free base

    go.drugbank.com/drugs/DB19310
    Experimental

    Synonyms: Rhodamine 123 free base
  5. Drug

    TAK-418 free base

    go.drugbank.com/drugs/DB16939
    Investigational

    Synonyms: TAK-418 free base, 5-((1R,2R)-2-((Cyclopropylmethyl)amino)cyclopropyl)-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide
  6. Drug

    Palladium Pd-103

    go.drugbank.com/drugs/DB15016
    Experimental

    Palladium Pd-103 is under investigation in clinical trial NCT00247312 (Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized Trial).

  7. Drug

    Reserpine

    go.drugbank.com/drugs/DB00206
    ApprovedWithdrawn

    The FDA withdrew its approval for the use of all oral dosage form drug products containing more than 1 mg of reserpine.[L43942] … It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.

    Mixtures: Hydropres 50 Tab, REGROTON TABLET, 50 ADETCategories: Cytochrome P-450 CYP3A Inducers, Cytochrome P-450 CYP3A5 Inducers
  8. Drug

    Fexinidazole

    go.drugbank.com/drugs/DB12265
    Approved

    [A237550, A237560] Fexinidazole, which was originally developed in the 1970s/80s by Hoechst AG and subsequently rediscovered through the Drugs for Neglected Diseases Initiative (DNDi) in 2005, is the first … [A237555, A237560] Fexinidazole received a positive opinion from the European Medicines Agency (EMA) in November 2018 and was approved by the FDA on July 16, 2021.

    Categories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 Substrates
  9. Drug

    Sodium molybdate

    go.drugbank.com/drugs/DB14496
    Approved

    Synonyms: Molybdenum (as sodium)Mixtures: TRACUTIL® 10 ML AMPOLLAS, Luna Vitamin and Mineral Bar for Women
  10. Drug

    Podophyllin

    go.drugbank.com/drugs/DB09094
    Approved

    Podophyllin is a resin extracted from the roots of _Podophyllum peltatum_ (American mandrake) and _Podophyllum emodi_, which contains numerous compounds, amongst which is podophyllin (as well as the drug

    Mixtures: CANTHACUR PS %1,%5,%30 TOPIKAL SOLUSYON 7,5 ML, Cantharidin 1% / Podophyllum Resin 5% / Salicylic Acid 30%Products: Podofilm Liq 250mg/ml, PODOFILM %25 25 ML TOPIKAL SOLUSYON